AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)
AdaptHealth Corp. (NASDAQ: AHCO) shares fell as much as 26% after Q2 revenue of $740.3 million and a $0.99 GAAP loss missed expectations, alongside a $144.2 million goodwill impairment. Levi & Korsinsky is investigating potential securities law violations.
AdaptHealth Corp. (NASDAQ: AHCO) shares fell as much as 26% after the Company reported second quarter revenue of $740.3 million, well below approximately $847 million expected, a GAAP loss driven in part by a $144.2 million goodwill impairment charge, and a substantial reduction to full-year guidance. If you suffered a loss on your AdaptHealth investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
Adjusted EBITDA came in at $132 million for the quarter, against roughly $160 million expected. Alongside those results, AdaptHealth reset its 2026 continuing-operations outlook to approximately $2.85 billion to $2.89 billion in revenue and $490 million to $520 million in adjusted EBITDA. Management attributed the reset to the Diabetes Health divestiture, a capitated contract, manufacturer pricing, and other portfolio actions.
